Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human ADAM29 Protein, N-His

Catalog #:   YHK06301 Specific References (27) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q9UKF5
Protein length: Asn253-Arg670
Overview

Catalog No.

YHK06301

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Asn253-Arg670

Predicted molecular weight

49.11 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q9UKF5

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

ADAM 29, Cancer/testis antigen 73, Disintegrin and metalloproteinase domain-containing protein 29, ADAM29, CT73

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human ADAM29 protein
References

Loss of ADAM29 does not affect viability and fertility in mice but improves wound healing., PMID:38966569

Fermented Maillard reaction products attenuate stress-induced testicular dysfunction in mice., PMID:33272581

Transmembrane protein ADAM29 facilitates cell proliferation, invasion and migration in clear cell renal cell carcinoma., PMID:33164721

Expression of ADAM29 and FAM135B in the pathological evolution from normal esophageal epithelium to esophageal cancer: Their differences and clinical significance., PMID:32194665

Identification of TEX101-associated Proteins Through Proteomic Measurement of Human Spermatozoa Homozygous for the Missense Variant rs35033974., PMID:30429210

A cancer tissue-specific FAM72 expression profile defines a novel glioblastoma multiform (GBM) gene-mutation signature., PMID:30414097

Clinical significance of ADAM29 promoting the invasion and growth of gastric cancer cells in vitro., PMID:30008827

Multiple non-catalytic ADAMs are novel integrin α4 ligands., PMID:28913673

ADAM29 Expression in Human Breast Cancer and its Effects on Breast Cancer Cells In Vitro., PMID:26977022

Systematic identification of barriers to human iPSC generation., PMID:25036638

Association study of susceptibility loci with specific breast cancer subtypes in Chinese women., PMID:25007960

Gene expression profiles in peripheral blood mononuclear cells of Asian obstructive sleep apnea patients., PMID:24732660

Identification of genomic alterations in oesophageal squamous cell cancer., PMID:24670651

Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer., PMID:24325915

A cancer/testis antigen microarray to screen autoantibody biomarkers of non-small cell lung cancer., PMID:22922091

Impact of MUC1 mucin downregulation in the phenotypic characteristics of MKN45 gastric carcinoma cell line., PMID:22073229

Analysis of the disintegrin-metalloproteinases family reveals ADAM29 and ADAM7 are often mutated in melanoma., PMID:21618342

Assessment of the pathway of apoptosis involving PAR-4, DAXX and ZIPK proteins in CLL patients and its relationship with the principal prognostic factors., PMID:21526495

Natural killer-like T CD3+/CD16+CD56+ cells in chronic lymphocytic leukemia: intracellular cytokine expression and relationship with clinical outcome., PMID:20664990

BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features., PMID:19395025

IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide., PMID:19340428

Preliminarily functional analysis of a cloned novel human gene ADAM29., PMID:18726420

Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia., PMID:16840197

The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia., PMID:15802535

Screen and identification of proteins interacting with ADAM19 cytoplasmic tail., PMID:12463424

Molecular cloning and mapping of a novel ADAM gene (ADAM29) to human chromosome 4., PMID:10644455

Isolation of two novel metalloproteinase-disintegrin (ADAM) cDNAs that show testis-specific gene expression., PMID:10512762

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human ADAM29 Protein, N-His [YHK06301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only